APO Research

APO RESEARCH · REPORT

Synthetic Biology Automation Platform

Selected research

Market Outlook & Growth Opportunities

Global Synthetic Biology Automation Platform Market Outlook and Growth Opportunities 2026

Market perspective

The global Synthetic Biology Automation Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Synthetic Biology Automation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Synthetic Biology Automation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Synthetic Biology Automation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Synthetic Biology Automation Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Synthetic Biology Automation Platform market include Ginkgo Bioworks, Amyris, Codexis, Ningbo Enzyme, Enhe Bio, Strateos, Asimov, Lattice Automation and HighRes Biosolutions, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Synthetic Biology Automation Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Synthetic Biology Automation Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Synthetic Biology Automation Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Synthetic Biology Automation Platform market.

Synthetic Biology Automation Platform Segment by Company

Ginkgo Bioworks

Amyris

Codexis

Ningbo Enzyme

Enhe Bio

Strateos

Asimov

Lattice Automation

HighRes Biosolutions

Integrated DNA Technologies (IDT)

Tidetron Bio

Synthetic Biology Automation Platform Segment by Type

small Production

Mass Production

Synthetic Biology Automation Platform Segment by Application

Chemicals

Pharmaceuticals

Food

Others

Synthetic Biology Automation Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Synthetic Biology Automation Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Synthetic Biology Automation Platform key companies, revenue, market share, and recent developments.

3. To split the Synthetic Biology Automation Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Synthetic Biology Automation Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Synthetic Biology Automation Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Synthetic Biology Automation Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synthetic Biology Automation Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Synthetic Biology Automation Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synthetic Biology Automation Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Synthetic Biology Automation Platform industry.

Chapter 3: Detailed analysis of Synthetic Biology Automation Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Synthetic Biology Automation Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Synthetic Biology Automation Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Synthetic Biology Automation Platform Industry Trends Table 2. Synthetic Biology Automation Platform Industry Drivers Table 3. Synthetic Biology Automation Platform Industry Opportunities and Challenges Table 4. Synthetic Biology Automation Platform Industry Restraints Table 5. Global Synthetic Biology Automation Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Synthetic Biology Automation Platform Revenue Share by Company (2021-2026) Table 7. Global Synthetic Biology Automation Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Synthetic Biology Automation Platform Key Company Manufacturing Base & Headquarters Table 9. Global Synthetic Biology Automation Platform Company, Product Type & Application Table 10. Global Synthetic Biology Automation Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Synthetic Biology Automation Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of small Production Table 15. Significant Companies of Mass Production Table 16. Global Synthetic Biology Automation Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Synthetic Biology Automation Platform Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Synthetic Biology Automation Platform Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Synthetic Biology Automation Platform Sales Value Share by Type (2021-2026) Table 20. Global Synthetic Biology Automation Platform Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Chemicals Table 22. Significant Companies of Pharmaceuticals Table 23. Significant Companies of Food Table 24. Significant Companies of Others Table 25. Global Synthetic Biology Automation Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Synthetic Biology Automation Platform Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Synthetic Biology Automation Platform Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Synthetic Biology Automation Platform Sales Value Share by Application (2021-2026) Table 29. Global Synthetic Biology Automation Platform Sales Value Share by Application (2027-2032) Table 30. Global Synthetic Biology Automation Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Synthetic Biology Automation Platform Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Synthetic Biology Automation Platform Sales Value Share by Region (2021-2026) Table 33. Global Synthetic Biology Automation Platform Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Synthetic Biology Automation Platform Sales Value Share by Region (2027-2032) Table 35. Global Synthetic Biology Automation Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Synthetic Biology Automation Platform Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Synthetic Biology Automation Platform Sales Value Market Share by Country (2021-2026) Table 38. Global Synthetic Biology Automation Platform Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Synthetic Biology Automation Platform Sales Value Market Share by Country (2027-2032) Table 40. Ginkgo Bioworks Company Information Table 41. Ginkgo Bioworks Business Overview Table 42. Ginkgo Bioworks Synthetic Biology Automation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Ginkgo Bioworks Synthetic Biology Automation Platform Product Portfolio Table 44. Ginkgo Bioworks Recent Development Table 45. Amyris Company Information Table 46. Amyris Business Overview Table 47. Amyris Synthetic Biology Automation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Amyris Synthetic Biology Automation Platform Product Portfolio Table 49. Amyris Recent Development Table 50. Codexis Company Information Table 51. Codexis Business Overview Table 52. Codexis Synthetic Biology Automation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Codexis Synthetic Biology Automation Platform Product Portfolio Table 54. Codexis Recent Development Table 55. Ningbo Enzyme Company Information Table 56. Ningbo Enzyme Business Overview Table 57. Ningbo Enzyme Synthetic Biology Automation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Ningbo Enzyme Synthetic Biology Automation Platform Product Portfolio Table 59. Ningbo Enzyme Recent Development Table 60. Enhe Bio Company Information Table 61. Enhe Bio Business Overview Table 62. Enhe Bio Synthetic Biology Automation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Enhe Bio Synthetic Biology Automation Platform Product Portfolio Table 64. Enhe Bio Recent Development Table 65. Strateos Company Information Table 66. Strateos Business Overview Table 67. Strateos Synthetic Biology Automation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Strateos Synthetic Biology Automation Platform Product Portfolio Table 69. Strateos Recent Development Table 70. Asimov Company Information Table 71. Asimov Business Overview Table 72. Asimov Synthetic Biology Automation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Asimov Synthetic Biology Automation Platform Product Portfolio Table 74. Asimov Recent Development Table 75. Lattice Automation Company Information Table 76. Lattice Automation Business Overview Table 77. Lattice Automation Synthetic Biology Automation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Lattice Automation Synthetic Biology Automation Platform Product Portfolio Table 79. Lattice Automation Recent Development Table 80. HighRes Biosolutions Company Information Table 81. HighRes Biosolutions Business Overview Table 82. HighRes Biosolutions Synthetic Biology Automation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. HighRes Biosolutions Synthetic Biology Automation Platform Product Portfolio Table 84. HighRes Biosolutions Recent Development Table 85. Integrated DNA Technologies (IDT) Company Information Table 86. Integrated DNA Technologies (IDT) Business Overview Table 87. Integrated DNA Technologies (IDT) Synthetic Biology Automation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Integrated DNA Technologies (IDT) Synthetic Biology Automation Platform Product Portfolio Table 89. Integrated DNA Technologies (IDT) Recent Development Table 90. Tidetron Bio Company Information Table 91. Tidetron Bio Business Overview Table 92. Tidetron Bio Synthetic Biology Automation Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Tidetron Bio Synthetic Biology Automation Platform Product Portfolio Table 94. Tidetron Bio Recent Development Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Synthetic Biology Automation Platform Product Image Figure 2. Global Synthetic Biology Automation Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Synthetic Biology Automation Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Synthetic Biology Automation Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. small Production Image Figure 8. Mass Production Image Figure 9. Global Synthetic Biology Automation Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Synthetic Biology Automation Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Synthetic Biology Automation Platform Sales Value Share by Type (2021-2032) Figure 12. Chemicals Image Figure 13. Pharmaceuticals Image Figure 14. Food Image Figure 15. Others Image Figure 16. Global Synthetic Biology Automation Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Synthetic Biology Automation Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Synthetic Biology Automation Platform Sales Value Share by Application (2021-2032) Figure 19. Global Synthetic Biology Automation Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Synthetic Biology Automation Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Synthetic Biology Automation Platform Sales Value (2021-2032) & (US$ Million) Figure 22. North America Synthetic Biology Automation Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Synthetic Biology Automation Platform Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Synthetic Biology Automation Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Synthetic Biology Automation Platform Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Synthetic Biology Automation Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Synthetic Biology Automation Platform Sales Value (2021-2032) & (US$ Million) Figure 28. South America Synthetic Biology Automation Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Synthetic Biology Automation Platform Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Synthetic Biology Automation Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • small Production
  • Mass Production
Applications
  • Chemicals
  • Pharmaceuticals
  • Food
  • Others
Companies covered
  • Ginkgo Bioworks
  • Amyris
  • Codexis
  • Ningbo Enzyme
  • Enhe Bio
  • Strateos
  • Asimov
  • Lattice Automation
  • HighRes Biosolutions
  • Integrated DNA Technologies (IDT)
  • Tidetron Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Synthetic Biology Automation Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Synthetic Biology Automation Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Synthetic Biology Automation Platform Market Dynamics
  1. 2.1 Synthetic Biology Automation Platform Industry Trends
  2. 2.2 Synthetic Biology Automation Platform Industry Drivers
  3. 2.3 Synthetic Biology Automation Platform Industry Opportunities and Challenges
  4. 2.4 Synthetic Biology Automation Platform Industry Restraints
3 Synthetic Biology Automation Platform Market by Company
  1. 3.1 Global Synthetic Biology Automation Platform Company Revenue Ranking in 2025
  2. 3.2 Global Synthetic Biology Automation Platform Revenue by Company (2021-2026)
  3. 3.3 Global Synthetic Biology Automation Platform Company Ranking (2024-2026)
  4. 3.4 Global Synthetic Biology Automation Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Synthetic Biology Automation Platform Company Product Type and Application
  6. 3.6 Global Synthetic Biology Automation Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Synthetic Biology Automation Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Synthetic Biology Automation Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Synthetic Biology Automation Platform Market by Type
  1. 4.1 Synthetic Biology Automation Platform Type Introduction
  2. 4.1.1 small Production
  3. 4.1.2 Mass Production
  4. 4.2 Global Synthetic Biology Automation Platform Sales Value by Type
  5. 4.2.1 Global Synthetic Biology Automation Platform Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Synthetic Biology Automation Platform Sales Value by Type (2021-2032)
  7. 4.2.3 Global Synthetic Biology Automation Platform Sales Value Share by Type (2021-2032)
5 Synthetic Biology Automation Platform Market by Application
  1. 5.1 Synthetic Biology Automation Platform Application Introduction
  2. 5.1.1 Chemicals
  3. 5.1.2 Pharmaceuticals
  4. 5.1.3 Food
  5. 5.1.4 Others
  6. 5.2 Global Synthetic Biology Automation Platform Sales Value by Application
  7. 5.2.1 Global Synthetic Biology Automation Platform Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Synthetic Biology Automation Platform Sales Value by Application (2021-2032)
  9. 5.2.3 Global Synthetic Biology Automation Platform Sales Value Share by Application (2021-2032)
6 Synthetic Biology Automation Platform Regional Value Analysis
  1. 6.1 Global Synthetic Biology Automation Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Synthetic Biology Automation Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Synthetic Biology Automation Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Synthetic Biology Automation Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Synthetic Biology Automation Platform Sales Value (2021-2032)
  7. 6.3.2 North America Synthetic Biology Automation Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Synthetic Biology Automation Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Synthetic Biology Automation Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Synthetic Biology Automation Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Synthetic Biology Automation Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Synthetic Biology Automation Platform Sales Value (2021-2032)
  16. 6.6.2 South America Synthetic Biology Automation Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Synthetic Biology Automation Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Synthetic Biology Automation Platform Sales Value Share by Country, 2025 VS 2032
7 Synthetic Biology Automation Platform Country-level Value Analysis
  1. 7.1 Global Synthetic Biology Automation Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Synthetic Biology Automation Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Synthetic Biology Automation Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Synthetic Biology Automation Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ginkgo Bioworks
  2. 8.1.1 Ginkgo Bioworks Company Information
  3. 8.1.2 Ginkgo Bioworks Business Overview
  4. 8.1.3 Ginkgo Bioworks Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ginkgo Bioworks Synthetic Biology Automation Platform Product Portfolio
  6. 8.1.5 Ginkgo Bioworks Recent Developments
  7. 8.2 Amyris
  8. 8.2.1 Amyris Company Information
  9. 8.2.2 Amyris Business Overview
  10. 8.2.3 Amyris Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amyris Synthetic Biology Automation Platform Product Portfolio
  12. 8.2.5 Amyris Recent Developments
  13. 8.3 Codexis
  14. 8.3.1 Codexis Company Information
  15. 8.3.2 Codexis Business Overview
  16. 8.3.3 Codexis Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Codexis Synthetic Biology Automation Platform Product Portfolio
  18. 8.3.5 Codexis Recent Developments
  19. 8.4 Ningbo Enzyme
  20. 8.4.1 Ningbo Enzyme Company Information
  21. 8.4.2 Ningbo Enzyme Business Overview
  22. 8.4.3 Ningbo Enzyme Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ningbo Enzyme Synthetic Biology Automation Platform Product Portfolio
  24. 8.4.5 Ningbo Enzyme Recent Developments
  25. 8.5 Enhe Bio
  26. 8.5.1 Enhe Bio Company Information
  27. 8.5.2 Enhe Bio Business Overview
  28. 8.5.3 Enhe Bio Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Enhe Bio Synthetic Biology Automation Platform Product Portfolio
  30. 8.5.5 Enhe Bio Recent Developments
  31. 8.6 Strateos
  32. 8.6.1 Strateos Company Information
  33. 8.6.2 Strateos Business Overview
  34. 8.6.3 Strateos Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Strateos Synthetic Biology Automation Platform Product Portfolio
  36. 8.6.5 Strateos Recent Developments
  37. 8.7 Asimov
  38. 8.7.1 Asimov Company Information
  39. 8.7.2 Asimov Business Overview
  40. 8.7.3 Asimov Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Asimov Synthetic Biology Automation Platform Product Portfolio
  42. 8.7.5 Asimov Recent Developments
  43. 8.8 Lattice Automation
  44. 8.8.1 Lattice Automation Company Information
  45. 8.8.2 Lattice Automation Business Overview
  46. 8.8.3 Lattice Automation Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lattice Automation Synthetic Biology Automation Platform Product Portfolio
  48. 8.8.5 Lattice Automation Recent Developments
  49. 8.9 HighRes Biosolutions
  50. 8.9.1 HighRes Biosolutions Company Information
  51. 8.9.2 HighRes Biosolutions Business Overview
  52. 8.9.3 HighRes Biosolutions Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 HighRes Biosolutions Synthetic Biology Automation Platform Product Portfolio
  54. 8.9.5 HighRes Biosolutions Recent Developments
  55. 8.10 Integrated DNA Technologies (IDT)
  56. 8.10.1 Integrated DNA Technologies (IDT) Company Information
  57. 8.10.2 Integrated DNA Technologies (IDT) Business Overview
  58. 8.10.3 Integrated DNA Technologies (IDT) Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Integrated DNA Technologies (IDT) Synthetic Biology Automation Platform Product Portfolio
  60. 8.10.5 Integrated DNA Technologies (IDT) Recent Developments
  61. 8.11 Tidetron Bio
  62. 8.11.1 Tidetron Bio Company Information
  63. 8.11.2 Tidetron Bio Business Overview
  64. 8.11.3 Tidetron Bio Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Tidetron Bio Synthetic Biology Automation Platform Product Portfolio
  66. 8.11.5 Tidetron Bio Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research